Screening recommendation for women taking tamoxifen.
作者信息
Kawabata H, Ueno T
出版信息
Lancet. 2001 Sep 22;358(9286):1018. doi: 10.1016/S0140-6736(01)06150-5.
Abstract
摘要
相似文献
1
Screening recommendation for women taking tamoxifen.
Lancet. 2001 Sep 22;358(9286):1018. doi: 10.1016/S0140-6736(01)06150-5.
2
Should tamoxifen users be screened for endometrial lesions?
Lancet. 1998 Jan 17;351(9097):155-7. doi: 10.1016/S0140-6736(05)78216-7.
3
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):65; author reply 67. doi: 10.1016/S0140-6736(05)71561-0.
4
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):65-6; author reply 67. doi: 10.1016/S0140-6736(05)71562-2.
5
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):65; author reply 67. doi: 10.1016/S0140-6736(00)03579-0.
6
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):68. doi: 10.1016/S0140-6736(05)71567-1.
7
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):68. doi: 10.1016/S0140-6736(05)71566-X.
8
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):66-7. doi: 10.1016/S0140-6736(05)71563-4.
9
Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
J Med Assoc Thai. 2001 Jul;84(7):1033-6.
10
Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer.
J Clin Oncol. 1999 Jul;17(7):1967-8. doi: 10.1200/JCO.1999.17.7.1967.
Zotero 插件